Get startedLog in
    Picture of Biogen logo

    BIIB — Biogen News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    All News

    Brief: UCB And Biogen Announce Positive DZP Phase 3 Study Results

    Picture of Biogen logoBiogen
    01/06/2026 06:06
    BRIEF-UCB And Biogen Announce Positive DZP Phase 3 Study Results
    June 1 (Reuters) - Ucb SA UCB.BR:
    • UCB AND BIOGEN ANNOUNCE PUBLICATION IN LANCET OF POSITIVE DAPIROLIZUMAB PEGOL (DZP) PHASE 3 STUDY RESULTS IN SYSTEMIC LUPUS ERYTHEMATOSUS
    • RESULTS SHOWED STATISTICALLY SIGNIFICANT IMPROVEMENT IN DISEASE ACTIVITY WITH DZP VERSUS PLACEBO
    Source text: https://tinyurl.com/be5uxddb
    Further company coverage: UCB.BR

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Biogen

    See all news